Korea I.T.S (CEO Sungjin Choi), a leading healthcare technology company, has been recognized for its groundbreaking innovations by winning Innovation Awards in three categories—Digital Health, Mobile Devices, Accessories & Apps, and Human Security—at CES 2025.
The award-winning product, QuickGly, is the world’s first non-invasive device capable of measuring glycated hemoglobin (HbA1c) in real time, revolutionizing diabetes management. Unlike traditional blood glucose monitors, QuickGly measures HbA1c, which reflects the average blood sugar levels over the past three months, providing users with more accurate and comprehensive data. Additionally, it supports Bluetooth connectivity with iOS and Android devices for real-time data monitoring and features a built-in LCD display and voice guidance for enhanced accessibility.
A Fusion of Design, Technology, and Sustainable Innovation
QuickGly maximizes user convenience with its compact size and sleek design, reminiscent of a cosmetic case, which combines portability and style. Its eco-friendly construction using recyclable materials underscores the company’s commitment to sustainability. Powered by an integrated AI algorithm, QuickGly leverages advanced methodologies including the Beer-Lambert Law, Photon Diffusion, Monte Carlo Simulation, and machine learning models to ensure precise HbA1c measurements.
Advancing Global Healthcare Access
QuickGly offers a low-cost solution that is easy to use, even in regions with limited healthcare infrastructure, broadening access to diabetes management through remote diagnostics and monitoring.
This remarkable achievement at CES 2025 solidifies Korea I.T.S’s position as a global leader in healthcare innovation. QuickGly, slated for release in 2025, is expected to provide consumers worldwide with a groundbreaking, non-invasive diabetes management solution.
For more information about QuickGly, visit the official QuickGly website.
RM#920, Gangnam ACE Tower, 174-10, Jagok-ro, Gangnam-gu, Seoul, 06373, Korea
QuickGly@KoreaIts.com 
82-2-2421-4022
Korea I.T.S (CEO Sungjin Choi), a leading healthcare technology company, has been recognized for its groundbreaking innovations by winning Innovation Awards in three categories—Digital Health, Mobile Devices, Accessories & Apps, and Human Security—at CES 2025.
The award-winning product, QuickGly, is the world’s first non-invasive device capable of measuring glycated hemoglobin (HbA1c) in real time, revolutionizing diabetes management. Unlike traditional blood glucose monitors, QuickGly measures HbA1c, which reflects the average blood sugar levels over the past three months, providing users with more accurate and comprehensive data. Additionally, it supports Bluetooth connectivity with iOS and Android devices for real-time data monitoring and features a built-in LCD display and voice guidance for enhanced accessibility.
A Fusion of Design, Technology, and Sustainable Innovation
QuickGly maximizes user convenience with its compact size and sleek design, reminiscent of a cosmetic case, which combines portability and style. Its eco-friendly construction using recyclable materials underscores the company’s commitment to sustainability. Powered by an integrated AI algorithm, QuickGly leverages advanced methodologies including the Beer-Lambert Law, Photon Diffusion, Monte Carlo Simulation, and machine learning models to ensure precise HbA1c measurements.
Advancing Global Healthcare Access
QuickGly offers a low-cost solution that is easy to use, even in regions with limited healthcare infrastructure, broadening access to diabetes management through remote diagnostics and monitoring.
This remarkable achievement at CES 2025 solidifies Korea I.T.S’s position as a global leader in healthcare innovation. QuickGly, slated for release in 2025, is expected to provide consumers worldwide with a groundbreaking, non-invasive diabetes management solution.
For more information about QuickGly, visit the official QuickGly website.